Contract research organization JSS Medical Research Inc has secured an undisclosed equity investment from Capital Croissance PME (CCPME), a fund affiliate of the Caisse de dépôt et placement du Québec and Capital régional et coopératif Desjardins. Proceeds will be used to support the company’s consolidation in Latin America and Canada and help advance its expansion into the emerging markets. Based in Montréal, JSS Medical offers comprehensive clinical trial management services, from study design to publication of results, in Phase I-IV trials across a broad range of therapeutic areas. CCPME II was capitalized at $230 million in April 2013.
JSS Medical Research Inc. announces equity investment by Capital Croissance PME (CCPME)
CCPME is a fund jointly set up by the Caisse de dépôt et placement du Québec (“CDPQ”) and by Capital régional et coopératif Desjardins (“CRCD”)
MONTREAL, Oct. 1st 2014 /CNW Telbec/ – JSS Medical Research Inc., a Montreal based Contract Research Organization (CRO), conducting Phase I – IV Clinical Trials, Post Marketing Observational Studies as well as Epidemiological and Health Economics Research for Pharmaceutical, Biotechnology and Device companies, announced today that it concluded an equity investment transaction with Capital Croissance PME (CCPME) in support of its growth and expansion strategy. CCPME is a fund jointly set up by the Caisse de dépôt et placement du Québec (“CDPQ”) and by Capital régional et coopératif Desjardins (“CRCD”).
The proceeds of the current investment will support the company’s consolidation in Latin America and Canada and help further advance its international expansion into the emerging markets of Latin America (Argentina, Chile Mexico and Brazil), Europe and Asia.
Over the years, the successful design, execution, analysis and publication of registrational and post approval studies, the key differentiator of the company, has been a pivotal factor in its success that has attracted the attention of international clients. During the last five years and in response to its clients’ demands, the company has expanded its operations and currently conducts studies in Latin America, Europe and Asia.
The increase in requests for international studies led to the initiation of the company’s expansion plan with the acquisition of Latam Clinical Trials (now known as JSS Medical Research Latam S.A.S.), a CRO based in Bogota, Colombia, in September of 2013, that seeded the company’s presence in Latin America. The merger with Integrated Research, a Montreal based CRO, consolidated its position as the largest Canadian owned CRO. “Of course, none of this would be possible without the hard work and commitment of the JSS Medical Research employees and management team. I am honored to be working with this group of dedicated professionals,” stated the founder and CEO Dr. John. S. Sampalis.
About JSS Medical Research
JSS Medical Research is a full-service Contract Research Organization with its corporate office in Montreal, Canada and a regional office in Bogota, Colombia. The company offers comprehensive clinical trial management services, from study design to publication of results, in Phase I-IV trials across a broad range of therapeutic areas. Biotechnology companies rely on the company’s knowledgeable project teams, and its customer-centric and flexible approach to successfully conduct their critical early phase trials, while pharmaceutical companies can leverage its niche post-marketing service offerings. With science and clinical epidemiological expertise at its core, JSS Medical Research is a leader in Post-Approval Clinical Epidemiology Studies (PACES) including Post-Marketing Observational Studies, Health Outcomes Research and Health Economics. Currently JSS Medical Research is conducting research studies in over 20 countries around the world for its clients which include the top 25 international Pharmaceutical companies and Biotechnology/Device companies, worldwide.
For more information, visit www.jssresearch.com.
Photo courtesy of Shutterstock